Cerus Corporation
CERS
#7598
Rank
A$0.71 B
Marketcap
A$3.57
Share price
7.23%
Change (1 day)
86.10%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): -A$1.7 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$9.84 Million, an increase over its 2024 earnings that were of -A$16.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.7 Million-82.76%
2025 -A$9.84 Million-41.58%
2024 -A$16.84 Million-58.95%
2023 -A$41.01 Million-20.74%
2022 -A$51.73 Million-25.7%
2021 -A$69.63 Million-11.99%
2020 -A$79.11 Million-14%
2019 -A$91.99 Million21.73%
2018 -A$75.57 Million-0.65%
2017 -A$76.06 Million-10.96%
2016 -A$85.43 Million4.24%
2015 -A$81.96 Million50.99%
2014 -A$54.28 Million-10.08%
2013 -A$60.37 Million184.13%
2012 -A$21.25 Million-7.91%
2011 -A$23.07 Million
2009 -A$32.58 Million-24.69%
2008 -A$43.27 Million-25.2%
2007 -A$57.84 Million330.54%
2006 -A$13.44 Million1.49%
2005 -A$13.24 Million-61.02%
2004 -A$33.96 Million
2002 -A$84 Million10.02%
2001 -A$76.35 Million34.25%
2000 -A$56.87 Million61.02%
1999 -A$35.32 Million-18.81%
1998 -A$43.51 Million93.08%
1997 -A$22.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.30 B-343,088.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$19.03 M-1,331.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.22 B-14,466.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$21.14 Million 1,267.28%๐Ÿ‡บ๐Ÿ‡ธ USA